CD4 and autoimmune hepatitis: This glycosylation deficit increases CD4+ T cell infiltration and impacts Treg differentiation, thus disrupting the Notch signaling in CD4+ T cells and accelerating AIH progression.316 Further, O-glycosylation inhibitors have been shown to worsen AIH, potentially due to altered cytokine levels and T-cell proliferation.317